Balance Performance and Quality of Life in Parkinson's Disease
The Relationship Between Performance-Based Balance Tests and Quality of Life in Individuals With Parkinson's Disease
This observational study aims to examine the relationship between performance-based balance test results and quality of life in individuals with Parkinson's disease. It also seeks to determine which balance test best explains quality of life in this population.
Balance and functional performance will be assessed using the Six Spot Step Test, 30-Second Chair Stand Test, Timed Up and Go Test, Four Square Step Test, Berg Balance Scale, and 3-Meter Backward Walk Test. Quality of life will be evaluated using the 39-item Parkinson's Disease Questionnaire (PDQ-39). The findings may help clinicians select appropriate assessment methods and develop rehabilitation programs that address the factors associated with quality of life in individuals with Parkinson's disease.
Studieöversikt
Status
Betingelser
Studietyp
Inskrivning (Beräknad)
Kontakter och platser
Studiekontakt
- Namn: Büşra ÖZCAN, MSc
- Telefonnummer: +905533514349
- E-post: busra6873@gmail.com
Studera Kontakt Backup
- Namn: Borna FARHOOMAND, MSc
- Telefonnummer: +90544 903 36 38
- E-post: borna.farhoomand@gmail.com
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
The study population will consist of individuals diagnosed with idiopathic Parkinson's disease who are followed at the Neurology Department of Pamukkale University Hospital and age- and sex-matched healthy individuals recruited from the same geographical region in Denizli, Türkiye.
Beskrivning
Inclusion Criteria:
- Willing to participate in the study and providing written informed consent
- Having a diagnosis of idiopathic Parkinson's disease
- Being 20 years of age or older
- Being classified as stage 1-3 according to the Modified Hoehn and Yahr Scale
- Being in the "on" medication state and undergoing assessment one hour after taking antiparkinsonian medication
Exclusion Criteria:
- Being a healthy individual matched for age and sex with a participant diagnosed with Parkinson's disease Willing to participate in the study and providing written informed consent Being 20 years of age or older
Studieplan
Hur är studien utformad?
Designdetaljer
- Observationsmodeller: CASE_CROSSOVER
- Tidsperspektiv: CROSS_SECTIONAL
Kohorter och interventioner
Grupp / Kohort |
|---|
|
Parkinson's Disease Group
Individuals diagnosed with Parkinson's disease who underwent assessments of balance, functional performance, fear of falling, disease severity, depressive symptoms, and quality of life. No intervention was administered as part of this observational study. |
|
Healthy Control Group
Age- and sex-matched healthy individuals without a diagnosis of Parkinson's disease who underwent balance and functional performance assessments. No intervention was administered as part of this observational study. |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Health-Related Quality of Life Assessed by the PDQ-39
Tidsram: During the single assessment session (approximately 25 minutes)
|
Health-related quality of life in individuals with Parkinson's disease will be assessed using the 39-item Parkinson's Disease Questionnaire (PDQ-39). The PDQ-39 Summary Index ranges from 0 to 100, with higher scores indicating poorer health-related quality of life. |
During the single assessment session (approximately 25 minutes)
|
Samarbetspartners och utredare
Sponsor
Studieavstämningsdatum
Studera stora datum
Studiestart (Beräknad)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- E-60116787-020-677981
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .